We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$88B
AUM Growth
+$3.05B
(+3.6%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-3.73%
Top 10 Holdings %
Top 10 Hldgs %
12.89%
Holding
2,253
New
146
Increased
815
Reduced
1,092
Closed
142
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$267M |
| 2 |
Home Depot
HD
|
+$252M |
| 3 |
Northrop Grumman
NOC
|
+$221M |
| 4 |
Gilead Sciences
GILD
|
+$175M |
| 5 |
Dollar General
DG
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HP
HPQ
|
+$287M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$278M |
| 3 |
Biogen
BIIB
|
+$244M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$198M |
| 5 |
Exelon
EXC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.05% |
| 2 | Financials | 14.3% |
| 3 | Healthcare | 13.64% |
| 4 | Consumer Discretionary | 13.24% |
| 5 | Industrials | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVBG
1551
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $894K | ﹤0.01% |
11,451
-818
| -7% | -$63.2K |
|
|
EIDX
1552
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $893K | ﹤0.01% |
15,556
+4,217
| +37% | +$209K |
|
|
AQUA
1553
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $879K | ﹤0.01% |
+46,359
| New | +$831K |
|
|
ACH
1554
Accendra Health
ACH
$106M
| $877K | ﹤0.01% |
169,554
+159,338
| +1,560% | +$1.02M |
|
1555
Kulicke & Soffa
KLIC
$4.59B
| $876K | ﹤0.01% |
32,195
+922
| +3% | +$22.7K |
|
1556
Liberty Broadband Class C
LBRDK
$5.13B
| $875K | ﹤0.01% |
6,996
+1,573
| +29% | +$183K |
|
1557
Intellia Therapeutics
NTLA
$1.69B
| $875K | ﹤0.01% |
59,637
+23,099
| +63% | +$321K |
|
1558
DXP Enterprises
DXPE
$3.02B
| $870K | ﹤0.01% |
21,859
-4,183
| -16% | -$156K |
|
|
OMN
1559
DELISTED
OMNOVA Solutions Inc.
OMN
| $868K | ﹤0.01% |
85,852
-5,417
| -6% | -$54.7K |
|
1560
ESCO Technologies
ESE
$7.81B
| $867K | ﹤0.01% |
9,369
+53
| +0.6% | +$4.52K |
|
1561
Keurig Dr Pepper
KDP
$40B
| $867K | ﹤0.01% |
29,943
| – | – |
|
|
INOV
1562
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $863K | ﹤0.01% |
45,848
+489
| +1% | +$8.18K |
|
1563
Denali Therapeutics
DNLI
$3.95B
| $857K | ﹤0.01% |
49,205
-19,789
| -29% | -$329K |
|
1564
Future Fuel
FF
$226M
| $853K | ﹤0.01% |
68,844
-59,102
| -46% | -$704K |
|
1565
Ionis Pharmaceuticals
IONS
$9.51B
| $852K | ﹤0.01% |
14,141
-10,652
| -43% | -$635K |
|
1566
Hope Bancorp
HOPE
$1.78B
| $847K | ﹤0.01% |
56,968
+21,769
| +62% | +$316K |
|
1567
Mueller Water Products
MWA
$4.1B
| $846K | ﹤0.01% |
70,584
-8,612
| -11% | -$98.4K |
|
1568
Univest Financial
UVSP
$1.16B
| $846K | ﹤0.01% |
31,591
+10,662
| +51% | +$276K |
|
|
UNVR
1569
DELISTED
Univar Solutions Inc.
UNVR
| $844K | ﹤0.01% |
+34,809
| New | +$788K |
|
1570
Eagle Materials
EXP
$6.43B
| $835K | ﹤0.01% |
9,266
+1,803
| +24% | +$165K |
|
1571
Mitek Systems
MITK
$840M
| $831K | ﹤0.01% |
108,684
-14,726
| -12% | -$124K |
|
|
CXO
1572
DELISTED
CONCHO RESOURCES INC.
CXO
| $828K | ﹤0.01% |
9,619
+767
| +9% | +$55.3K |
|
1573
Energizer
ENR
$1.5B
| $820K | ﹤0.01% |
16,355
+2,387
| +17% | +$110K |
|
1574
Freshpet
FRPT
$3.28B
| $820K | ﹤0.01% |
13,870
-4,695
| -25% | -$250K |
|
|
HPP
1575
Hudson Pacific Properties
HPP
$734M
| $816K | ﹤0.01% |
3,096
-247
| -7% | -$60.8K |
|
Similar funds
VGA
AQR Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, AQR Capital Management held 2,253 positions worth $88B, up 3.6% from $84.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management withdrew a net $3.28B in Q4 2019, closing 142 positions and reducing 1,092 holdings. Its most notable exit was iShares Russell 3000 ETF, an estimated $198M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, AQR Capital Management opened a new position in DaVita worth $31.1M.
- AQR Capital Management's largest Q4 2019 buy was DaVita: 417,883 shares worth $31.1M.
- AQR Capital Management added most to Humana in Q4 2019, an estimated $267M increase.
- AQR Capital Management's biggest Q4 2019 reduction was HP, cutting an estimated $287M.
- AQR Capital Management fully exited iShares Russell 3000 ETF in Q4 2019, selling an estimated $198M.
- AQR Capital Management's ten largest holdings make up 13% of its $88B portfolio in Q4 2019.
- AQR Capital Management opened 146 new positions and closed 142 in Q4 2019.
- AQR Capital Management's portfolio value rose 3.6% quarter-over-quarter to $88B.
Based on AQR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.